![John Houston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Houston
Direktor/Vorstandsmitglied bei
ARVINAS, INC.
Vermögen: 9 Mio $ am 31.05.2026
Profil
John G. Houston ist President, Chief Executive Officer & Director bei Arvinas, Inc. und President, Chief Executive Officer & Director bei Arvinas Operations, Inc. (eine Tochtergesellschaft von Arvinas, Inc.). Er ist auch Mitglied des Verwaltungsrats von NextCure, Inc. und Cybrexa, Inc. sowie von Oerth Bio LLC. John G. Houston hatte zuvor die Position des Senior Vice President-Specialty Discovery bei Bristol Myers Squibb Co. und des Head-Lead Discovery Unit bei GlaxoSmithKline Research & Development Ltd. inne. Er promovierte an der University of Glasgow und an der Heriot-Watt University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARVINAS, INC. 1.54% | 31.03.2026 | 992’689 ( 1.54% ) | 9 Mio $ | 31.05.2026 |
NEXTCURE, INC. -.--% | 22.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von John Houston
| Unternehmen | Position | Beginn |
|---|---|---|
| ARVINAS, INC. | Direktor/Vorstandsmitglied | 12.02.2026 |
| NEXTCURE, INC. | Direktor/Vorstandsmitglied | 10.09.2020 |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Vorstandsvorsitzender | 21.09.2017 |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Direktor/Vorstandsmitglied | 03.09.2019 |
Oerth Bio LLC
 Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products | Direktor/Vorstandsmitglied | 01.06.2019 |
Connecticut United for Research Excellence, Inc.
 Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services for biomedical research and biotechnology to advance and support research and technology | Direktor/Vorstandsmitglied | 01.12.2015 |
Bioct Innovation Commons | Direktor/Vorstandsmitglied | 01.12.2015 |
Ehemalige bekannte Positionen von John Houston
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.08.2016 |
GlaxoSmithKline Research & Development Ltd.
 GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as a commercial physical research company | Corporate Officer/Principal | - |
Ausbildung von John Houston
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heriot-Watt University
 Heriot-Watt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Connecticut United for Research Excellence, Inc.
Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services for biomedical research and biotechnology to advance and support research and technology | Commercial Services |
GlaxoSmithKline Research & Development Ltd.
GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as a commercial physical research company | Commercial Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Health Technology |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Bioct Innovation Commons | Finance |
